Dublin, June 28, 2018 (GLOBE NEWSWIRE) -- The "Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global wound debridement market is projected to grow at a CAGR of 8.2% during the forecast period
The wound debridement market is expected to reach USD 1,041.0 million by 2023 from USD 702.0 million in 2018, at a CAGR of 8.2%. Factors such as rising incidence of diabetes & associated wounds, growing aging population, rising incidence of burn injuries, and growing awareness programs for wound care treatment and management are driving the growth of the wound debridement market. The main factor hindering overall market growth is the high cost of advanced wound debridement products. Due to this, globally, preference is skewed towards the low-cost products in the market. The ultrasonic devices segment is estimated to grow at the fastest rate in the next five years
On the basis of product, the wound debridement market is segmented into gels, ointments & creams, surgical devices, ultrasound devices, mechanical debridement pads, medical gauzes, and other wound debridement products. Ultrasonic devices are expected to grow at the highest CAGR during the forecast period due to advantages such as their ability to differentiate between viable and non-viable tissue and their ability to destroy bacteria and biofilms without damaging blood vessels. In 2018, the autolytic methods segment is expected to dominate the wound debridement market
Based on method, the wound debridement market has been segmented into autolytic, enzymatic, surgical, mechanical, and other methods. In 2018, the autolytic methods segment is expected to register the largest market share during the forecast period. The large share of this segment is primarily due to its advantagesno damage to healthy tissue and ease of use. Asia Pacific is estimated to grow at the highest CAGR during the study period
Geographically, the wound debridement market is dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the fastest rate due to the increasing awareness regarding advanced treatment methods, increasing patient population, and the presence of emerging economies such as China and India.
The key players in the wound debridement market include Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), Misonix (US), ConvaTec (UK), Lohmann & Rauscher (Germany), DeRoyal Industries (US), Medline Industries (US), Mlnlycke Health Care AB (Sweden), and Integra LifeSciences (US).
Companies Mentioned
- B. Braun Melsungen AG
- Coloplast
- Convatec Group
- Deroyal Industries
- Integra Lifesciences
- Lohmann & Rauscher
- Medline Industries
- Misonix
- Mlnlycke Health Care AB
- Smith & Nephew
- Welcare Industries
Key Topics Covered
1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2 Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.2.1 Bottom-Up Approach 2.2.2 Top-Down Approach 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3 Executive Summary 4 Premium Insights 4.1 Wound Debridement Market Overview 4.2 Asia Pacific: Wound Debridement Market, By Product & Country 4.3 Wound Debridement Market, By Region 4.4 Geographical Snapshot of the Wound Debridement Market (By Major Countries) 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Rising Incidence of Diabetes and Associated Wounds 5.2.1.2 Growth in the Aging Population 5.2.1.3 Rising Incidence of Burn Injuries 5.2.1.4 Awareness Programs for Wound Care Treatment and Management 5.2.2 Market Opportunities 5.2.2.1 Lucrative Opportunities for New Entrants 5.2.2.2 Growth Potential of Emerging Economies 5.2.3 Market Trend 5.2.3.1 Focus on Autolytic Debridement & Disposable Products 6 Wound Debridement Market, By Product 6.1 Introduction 6.2 Gels 6.3 Ointments & Creams 6.4 Surgical Devices 6.5 Medical Gauzes 6.6 Mechanical Debridement Pads 6.7 Ultrasonic Devices 6.8 Other Wound Debridement Products 7 Wound Debridement Market, By Wound Type 7.1 Introduction 7.2 Venous Leg Ulcers 7.3 Diabetic Foot Ulcers 7.4 Pressure Ulcers 7.5 Surgical & Traumatic Wounds 7.6 Burns 7.7 Other Wounds 8 Wound Debridement Market, By Method 8.1 Introduction 8.2 Autolytic Methods 8.3 Enzymatic Methods 8.4 Surgical Methods 8.5 Mechanical Methods 8.6 Other Methods 9 Wound Debridement Market, By End User 9.1 Introduction 9.2 Hospitals 9.3 Clinics 9.4 Other End Users 10 Wound Debridement Market, By Region 10.1 Introduction 10.2 North America 10.2.1 US 10.2.2 Canada 10.3 Europe 10.3.1 Germany 10.3.2 France 10.3.3 UK 10.3.4 Italy 10.3.5 Spain 10.3.6 RoE 10.4 Asia Pacific 10.4.1 China 10.4.2 India 10.4.3 Japan 10.4.4 Rest of Asia Pacific 10.5 Rest of the World 11 Competitive Landscape 11.1 Overview 11.2 Market Share Analysis 11.3 Competitive Situation and Trends 11.3.1 Expansions 11.3.2 Product Launches 11.3.3 Collaborations 11.3.4 Acquisitions 12 Company Profiles 12.1 Smith & Nephew 12.2 B. Braun Melsungen AG 12.3 Coloplast 12.4 Misonix 12.5 Convatec Group 12.6 Lohmann & Rauscher 12.7 Deroyal Industries 12.8 Medline Industries 12.9 Mlnlycke Health Care AB 12.10 Integra Lifesciences 12.11 Welcare Industries
For more information about this report visit https://www.researchandmarkets.com/research/3..._1_04?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Wound Care
